PDK1 inhibitor,
1001409-50-2,
CHEMBL1234429,
MP7,
1-(3,4-Difluorobenzyl)-2-Oxo-N-{(1r)-2-[(2-Oxo-2,3-Dihydro-1h-Benzimidazol-5-Yl)oxy]-1-Phenylethyl}-1,2-Dihydropyridine-3-Carboxamide,
1-[(3,4-difluorophenyl)methyl]-2-oxo-N-[(1R)-2-[(2-oxo-1,3-dihydrobenzimidazol-5-yl)oxy]-1-phenylethyl]pyridine-3-carboxamide,
3qc4,
SCHEMBL13306609,
CHEBI:91373,
DTXSID90678515,
C28H22F2N4O4,
3961AH,
BDBM50361645,
ZINC58660574,
AKOS030526189,
CS-0709,
NCGC00346947-01,
NCGC00346947-02,
HY-14440,
W-5783,
BRD-K09186807-001-01-6,
(R)-1-(3,4-difluorobenzyl)-2-oxo-N-(2-((2-oxo-2,3-dihydro-1H-benzo[d]imidazol-5-yl)oxy)-1-phenylethyl)-1,2-dihydropyridine-3-carboxamide,
1-[(3,4-Difluorophenyl)methyl]-2-oxo-N-{(1R)-2-[(2-oxo-2,3-dihydro-1H-benzimidazol-5-yl)oxy]-1-phenylethyl}-1,2-dihydropyridine-3-carboxamide,
N-[(R)-1-Phenyl-2-[(2-oxo-2,3-dihydro-1H-benzoimidazole-5-yl)oxy]ethyl]-1-(3,4-difluorobenzyl)-2-oxo-1,2-dihydropyridine-3-carboxamide,